Author:
Valente Michael A.,Moran Brendan John
Publisher
Springer International Publishing
Reference59 articles.
1. Sugarbaker PH, Gianola FJ, Speyer JC, Wesley R, Barofsky I, Meyers CE. Prospective, randomized trial of intravenous versus intraperitoneal 5-fluorouracil in patients with advanced primary colon or rectal cancer. Surgery. 1985;98(3):414–22.
2. Interventional procedure guidance (IPG56) https://www.nice.org.uk/Guidance/ipg56.
3. Moran BJ, Cecil TD. The etiology, clinical presentation, and management of pseudomyxoma peritonei. Surg Oncol Clin N Am. 2003;12(3):585–603.
4. Fallis SA, Moran BJ. Management of pseudomyxoma peritonei. J BUON. 2015;20(Suppl 1):S47–55.
5. Carr NJ, Cecil TD, Mohamed F, et al. Peritoneal surface oncology group international. A consensus for classification and pathologic reporting of Pseudomyxoma Peritonei and associated appendiceal neoplasia: the results of the Peritoneal Surface Oncology Group International (PSOGI) modified Delphi process. Am J Surg Pathol. 2016;40(1):14–26.